FDA Inspection
Stason Pharmaceuticals, Inc.Stason Pharmaceuticals, Inc. – FDA Inspection, Aug 24, 2010
Record Details
This FDA Inspection record concerns Stason Pharmaceuticals, Inc., with an inspection on August 24, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Stason Pharmaceuticals, Inc.
- Inspection Date
- August 24, 2010
- Product Type
- Drugs
View Company Profile
ID · 3b1aa5d1-f7d4-48a1-aef3-0986e94e6219
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 677200
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 314.80(c)(2)Interval
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Stason Pharmaceuticals, Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| April 13, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 25, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 24, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 14, 2017 | VAI | Los Angeles District Office | Generic Drug Evaluation |
| March 8, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Stason Pharmaceuticals, Inc.
- FDA Inspection 1140029 - 2021-04-13
- FDA Inspection 1109969 - 2019-10-25
- FDA Inspection 1067952 - 2018-08-24
- FDA Inspection 1014137 - 2017-06-14
- FDA Inspection 960658 - 2016-03-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.